BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int. 2018;12:1-10. [PMID: 29064029 DOI: 10.1007/s12072-017-9827-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 de Miguel MP, Prieto I, Moratilla A, Arias J, Aller MA. Mesenchymal Stem Cells for Liver Regeneration in Liver Failure: From Experimental Models to Clinical Trials. Stem Cells Int 2019;2019:3945672. [PMID: 31191671 DOI: 10.1155/2019/3945672] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
2 Møller S, Kimer N, Barløse M, Bendtsen F. Pathophysiological-based treatments of complications of cirrhosis. Scand J Gastroenterol 2020;55:383-94. [PMID: 32233873 DOI: 10.1080/00365521.2020.1744709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Li YH, Wu JF, Wu HM, Wu XN, Xu Y, Wan YM. The Effect of Transjugular Intrahepatic Portosystemic Shunt Plus Partial Splenic Embolization for the Treatment of Patients with Recurrent Variceal Bleeding. Acad Radiol 2020;27:323-31. [PMID: 31147236 DOI: 10.1016/j.acra.2019.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Xu G, Li F, Mao YL. Comment on "Intraoperative Increase of Portal Venous Pressure is an Immediate Predictor of Posthepatectomy Liver Failure After Major Hepatectomy": A Prospective Study. Ann Surg 2021;274:e688-9. [PMID: 32224744 DOI: 10.1097/SLA.0000000000003822] [Reference Citation Analysis]
5 Ryou M, Stylopoulos N, Baffy G. Nonalcoholic fatty liver disease and portal hypertension. Explor Med 2020;1:149-69. [PMID: 32685936 DOI: 10.37349/emed.2020.00011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Zhou C, Huang Y, Shu C, Zhou J, Hu X, Wang J, Wang Y, Zhang Z, Chen L, Chen X, Zhang Z. Splenectomy before hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A retrospective study. Medicine (Baltimore) 2021;100:e24326. [PMID: 33530224 DOI: 10.1097/MD.0000000000024326] [Reference Citation Analysis]
7 Xu G, Li F, Mao Y. Portal pressure monitoring-state-of-the-art and future perspective. Ann Transl Med. 2019;7:583. [PMID: 31807564 DOI: 10.21037/atm.2019.09.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Quan X, Tai Y, Wei B, Tong H, Wang Z, Yang Y, Wu H. Angioplasty With Stent Implantation for Portal Venous Stenosis Caused by Abdominal Tuberculosis: A Case Report and Literature Review. Front Med (Lausanne) 2021;8:778672. [PMID: 34778328 DOI: 10.3389/fmed.2021.778672] [Reference Citation Analysis]
9 Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316. [PMID: 34337369 DOI: 10.1016/j.jhepr.2021.100316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Bartolini I, Risaliti M, Fortuna L, Agostini C, Ringressi MN, Taddei A, Muiesan P. Current management of intrahepatic cholangiocarcinoma: from resection to palliative treatments. Radiol Oncol 2020;54:263-71. [PMID: 32726292 DOI: 10.2478/raon-2020-0045] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zou Z, Yan X, Lu H, Qi X, Gu Y, Li X, Wu B, Qi X. Comparison of drugs facilitating endoscopy for patients with acute variceal bleeding: a systematic review and network meta-analysis. Ann Transl Med 2019;7:717. [PMID: 32042733 DOI: 10.21037/atm.2019.12.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fang Q, Chen W, Jian Y, Li Y, Lian W, Wan H, Chen S, Li F, Chen Y, Ali L. Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection. Journal of Healthcare Engineering 2022;2022:1-7. [DOI: 10.1155/2022/8430276] [Reference Citation Analysis]
13 Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, Zheng C, Lin S, Qian K, Feng G, Xiong B. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage. J Gastroenterol Hepatol 2020;35:278-83. [PMID: 31222830 DOI: 10.1111/jgh.14761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Kreisel W, Lazaro A, Trebicka J, Grosse Perdekamp M, Schmitt-Graeff A, Deibert P. Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications. Int J Mol Sci 2021;22:10372. [PMID: 34638713 DOI: 10.3390/ijms221910372] [Reference Citation Analysis]
15 Gracia-sancho J, Marrone G, Fernández-iglesias A. Hepatic microcirculation and mechanisms of portal hypertension. Nat Rev Gastroenterol Hepatol 2019;16:221-34. [DOI: 10.1038/s41575-018-0097-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 13.5] [Reference Citation Analysis]
16 Gege C, Hambruch E, Hambruch N, Kinzel O, Kremoser C. Nonsteroidal FXR Ligands: Current Status and Clinical Applications. In: Fiorucci S, Distrutti E, editors. Bile Acids and Their Receptors. Cham: Springer International Publishing; 2019. pp. 167-205. [DOI: 10.1007/164_2019_232] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
17 Kotani K, Uchida-Kobayashi S, Yamamoto A, Kawamura E, Enomoto M, Higashiyama S, Kawabe J, Shiomi S, Tamori A, Kawada N. Per-rectal portal scintigraphy as an alternative measure of hepatic venous pressure gradient in chronic liver disease: A preliminary report. Clin Physiol Funct Imaging 2021;41:334-41. [PMID: 33843126 DOI: 10.1111/cpf.12703] [Reference Citation Analysis]
18 Wang JB, Gao Y, Liu JW, Dai MG, Yang SW, Ye B. Gastroesophageal varices in a patient presenting with essential thrombocythemia: A case report. World J Clin Cases 2021; 9(8): 1871-1876 [PMID: 33748236 DOI: 10.12998/wjcc.v9.i8.1871] [Reference Citation Analysis]
19 Oye M, Sanders K, Ghali M, Alkhasawneh A. Multiple myeloma with hepatic amyloid light-chain amyloidosis manifesting as progressive liver failure. BMJ Case Rep 2020;13:e234637. [PMID: 32601138 DOI: 10.1136/bcr-2020-234637] [Reference Citation Analysis]
20 Kong J, Shen S, Wang W. Synchronous hepatectomy and splenectomy vs hepatectomy for selected patients with hepatocellular carcinoma and clinically significant portal hypertension: A systematic review and meta-analysis. J Surg Oncol 2019;119:964-73. [PMID: 30775785 DOI: 10.1002/jso.25392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
21 Chen Z, Cai M, Wang X, Zhou Y, Chen J, Xie Q, Zhao Y, Xie K, Fang Q, Pu T, Jiang D, Bai T, Ma J, Geng X, Liu F. Two novel online nomograms for predicting the survival of individual patients undergoing partial hepatectomy for huge hepatocellular carcinoma. HPB (Oxford) 2021;23:1217-29. [PMID: 33413992 DOI: 10.1016/j.hpb.2020.12.002] [Reference Citation Analysis]
22 Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E, Bauer DJM, Paternostro R, Schwabl P, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut 2021;70:1758-67. [PMID: 33199442 DOI: 10.1136/gutjnl-2020-322712] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
23 Praktiknjo M, Monteiro S, Grandt J, Kimer N, Madsen JL, Werge MP, William P, Brol MJ, Turco L, Schierwagen R, Chang J, Klein S, Uschner FE, Welsch C, Moreau R, Schepis F, Bendtsen F, Gluud LL, Møller S, Trebicka J. Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure. Liver Int 2020;40:1457-66. [PMID: 32162397 DOI: 10.1111/liv.14433] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
24 Jindal A, Bhardwaj A, Kumar G, Sarin SK. Clinical Decompensation and Outcomes in Patients With Compensated Cirrhosis and a Hepatic Venous Pressure Gradient ≥20 mm Hg. Am J Gastroenterol 2020;115:1624-33. [PMID: 32453061 DOI: 10.14309/ajg.0000000000000653] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Baffy G, Bosch J. Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it? J Hepatol 2021:S0168-8278(21)02090-0. [PMID: 34606912 DOI: 10.1016/j.jhep.2021.09.029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Dong G, Huang X, Jiang S, Ni L, Chen S. Simvastatin Mitigates Apoptosis and Transforming Growth Factor-Beta Upregulation in Stretch-Induced Endothelial Cells. Oxid Med Cell Longev 2019;2019:6026051. [PMID: 31934265 DOI: 10.1155/2019/6026051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2019;31:626-632. [PMID: 30550458 DOI: 10.1097/meg.0000000000001342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Khanna R, Sarin SK. Noncirrhotic Portal Hypertension: Current and Emerging Perspectives. Clin Liver Dis. 2019;23:781-807. [PMID: 31563222 DOI: 10.1016/j.cld.2019.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Gao J, Wei B, Liu M, Hirsova P, Sehrawat TS, Cao S, Hu X, Xue F, Yaqoob U, Kang N, Cui H, Pomerantz WCK, Kostallari E, Shah VH. Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling. Hepatology 2021;73:2468-83. [PMID: 33159815 DOI: 10.1002/hep.31617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
30 Zheng S, Sun P, Liu X, Li G, Gong W, Liu J. Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: A single-center experience. Medicine (Baltimore) 2018;97:e13703. [PMID: 30558084 DOI: 10.1097/MD.0000000000013703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Zhang Y, Zhang L, Wang M, Luo X, Wang Z, Wang G, Guo X, Wei F, Zhang Y. Selective Esophagogastric Devascularization in the Modified Sugiura Procedure for Patients with Cirrhotic Hemorrhagic Portal Hypertension: A Randomized Controlled Trial. Can J Gastroenterol Hepatol 2020;2020:8839098. [PMID: 33354559 DOI: 10.1155/2020/8839098] [Reference Citation Analysis]
32 Maluf-Filho F, Meyer A, Martins PPM, Galvão FHF, D'Albuquerque LAC. Experimental model of portal hypertension and esophagogastric varices in minipigs: pressure and endoscopic pilot study. Acta Cir Bras 2022;37:e370103. [PMID: 35262597 DOI: 10.1590/acb370103] [Reference Citation Analysis]
33 Mitten EK, Baffy G. Microbiota transplantation in portal hypertension: promises and pitfalls. Clin Sci (Lond) 2022;136:425-9. [PMID: 35333331 DOI: 10.1042/CS20220029] [Reference Citation Analysis]
34 Königshofer P, Brusilovskaya K, Schwabl P, Reiberger T. Animal models of portal hypertension. Biochim Biophys Acta Mol Basis Dis 2019;1865:1019-30. [PMID: 30055295 DOI: 10.1016/j.bbadis.2018.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Zhang H, Lv W, Diao H, Shang L, Hussein AF. Reconstruction Algorithm-Based CT Imaging for the Diagnosis of Hepatic Ascites. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/1809186] [Reference Citation Analysis]
36 Saruwatari J, Dong C, Utsumi T, Tanaka M, McConnell M, Iwakiri Y. Integrated analysis of microRNA and mRNA expression profiles in splenomegaly induced by non-cirrhotic portal hypertension in rats. Sci Rep 2018;8:17983. [PMID: 30573742 DOI: 10.1038/s41598-018-36297-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Zhang W, Peng C, Zhang S, Huang S, Shen S, Xu G, Zhang F, Xiao J, Zhang M, Zhuge Y, Wang L, Zou X, Lv Y. EUS-guided portal pressure gradient measurement in patients with acute or subacute portal hypertension. Gastrointest Endosc 2021;93:565-72. [PMID: 32615178 DOI: 10.1016/j.gie.2020.06.065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]